Canopy Growth Corp

Canopy Growth Corp(CGC)股票分析

$0.720

+0.004 (+0.60%)收盘时

Loading chart…
最高
0.731
开盘
0.717
成交量加权均价
0.72
成交量
1.56M
市值
508.24M
最低
0.710
成交额
1.12M
企业价值/息税折旧摊销前利润(TTM)
-5.78

Canopy Growth Corporation is a cannabis company, which produces, distributes, and sells a diverse range of cannabis and cannabis-related products for both adult-use and medical purposes. The Company brands include tweed, DOJA, LivRelief Infused, Deep Space, Ace Valley, 7ACRES, Vert, Twd, Wana, Hiway and Canopy Medical. The LivRelief Infused is transdermal creams contain a delivery system designed to penetrate a range of cannabidiol (CBD) and tetrahydrocannabinol (THC). The Deep Space offers beverages and gummies, containing the THC potency available in the Canadian market. The Ace Valley is a cannabis brand focused on ready-to-enjoy beverages. The 7ACRES offers products that are crafted by cannabis enthusiasts. The Wana gummies are created with a handcrafted recipe made with pectin, not gelatin, creating a gluten-free shelf-stable recipe that doesn’t melt. Its Canopy Medical is a pharmaceutical manufacturer for the production, import and release of medical cannabis products in Germany.

AI 分析 of Canopy Growth Corp (CGC)

卖出

Canopy Growth Corp is not a good buy right now due to its current price of 0.713, a very low RSI of 17.94 indicating oversold conditions, and a troubling forward P/E of 20.37, which suggests high expectations despite ongoing losses.

估值指标

Canopy Growth Corp(CGC)当前预期市盈率为 20.37,5 年平均预期市盈率为 -1.20。

预期市盈率

严重高估
5 年均值 P/E
-1.20
当前P/E
20.37
高估
8.77
低估
-11.17

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-274.91
当前EV/EBITDA
-5.78
高估
449.41
低估
-999.23

预期市销率

合理
5 年均值 P/S
2.92
当前P/S
0.85
高估
5.19
低估
0.65

Alphio AI 对 CGC 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%CGC

$1.78

情景价格

基

基准

基准 · 50%CGC

$1.69

情景价格

悲

悲观

悲观 · 25%CGC

$1.41

情景价格

事件时间线

2026-09-28 (ET)

08:00:00

Canopy Growth Appoints Sebastian Blote as Country Manager for Germany

08:00:00

Canopy Growth Appoints Sebastian Blote as Country Manager for Germany

2026-09-22 (ET)

08:00:00

Canopy Growth Supplies Medical Cannabis Flowers to the UK

2026-09-08 (ET)

08:00:00

Canopy Growth Expands Medical Cannabis Portfolio in Australia

2026-08-07 (ET)

07:30:00

Company Reports Q1 Revenue of C$100.4M

资讯

CGC 常见问题 —— 由 Alphio AI 解答

Canopy Growth Corporation is a cannabis company, which produces, distributes, and sells a diverse range of cannabis and cannabis-related products for both adult-use and medical purposes. The Company brands include tweed, DOJA, LivRelief Infused, Deep Space, Ace Valley, 7ACRES, Vert, Twd, Wana, Hiway and Canopy Medical. The LivRelief Infused is transdermal creams contain a delivery system designed to penetrate a range of cannabidiol (CBD) and tetrahydrocannabinol (THC). The Deep Space offers beverages and gummies, containing the THC potency available in the Canadian market. The Ace Valley is a cannabis brand focused on ready-to-enjoy beverages. The 7ACRES offers products that are crafted by cannabis enthusiasts. The Wana gummies are created with a handcrafted recipe made with pectin, not gelatin, creating a gluten-free shelf-stable recipe that doesn’t melt. Its Canopy Medical is a pharmaceutical manufacturer for the production, import and release of medical cannabis products in Germany. It operates in the Healthcare sector (MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry).

Canopy Growth Corp is not a good buy right now due to its current price of 0.713, a very low RSI of 17.94 indicating oversold conditions, and a troubling forward P/E of 20.37, which suggests high expectations despite ongoing losses.

0xSkewfalcon2026/9/27

As mid-term elections approach and marijuana legalization comes up for debate again, $CGC is a chart worth watching. A large triangle pattern is close to a breakout. If it can reclaim its 50 DMA, there could be upside ahead 📈🌿 $1+ looks fairly likely again in the near future.

展开
注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易